Article
Targeting ALK1 to block LDL transcytosis and halt atherosclerosis - Nature Reviews Cardiology
Rating:
0.0
Views:
64
Likes:
1
Library:
1
In a mouse model of atherosclerosis, a selective monoclonal antibody that blocks the binding of LDL to activin receptor-like kinase 1 reduced plaque formation in the aorta.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value